5
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Preparation and Partial Characterization of a Pancreatic Cancer-Associated Glycoprotein Expressing CA50

, , , , , , , & show all
Pages 1307-1318 | Received 21 May 1991, Accepted 05 Aug 1991, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

G. L. Shue, S. Kawa, M. Kato, H. Oguchi, T. Kobayashi, T. Koiwai, M. Tokoo, S. Furuta, M. Kanai & T. Homma. (1993) Expression of Glycoconjugates in Pancreatic, Gastric, and Colonic Tissue by Bauhinia purpurea, Vicia villosa, and Peanut Lectins. Scandinavian Journal of Gastroenterology 28:7, pages 599-604.
Read now
S. Kawa, M. Kato, H. Oguchi, G. L. Hsue, T. Kobayashi, T. Koiwai, M. Tokoo, S. Furuta, T. Ichikawa & M. Kanai. (1992) Clinical Evaluation of Pancreatic Cancer-Associated Mucin Expressing CA19-9, CA50, Span-1, Sialyl-SSEA-l, and Dupan-2. Scandinavian Journal of Gastroenterology 27:8, pages 635-643.
Read now

Articles from other publishers (5)

Poh-Choo Pang, Stuart M. Haslam, Anne Dell & Gary F. Clark. (2016) The human fetoembryonic defense system hypothesis: Twenty years on. Molecular Aspects of Medicine 51, pages 71-88.
Crossref
Yoshinori Inagaki, Peipei Song, Wei Tang & Norihiro Kokudo. (2015) Cancer-associated carbohydrate antigens for clinical diagnostic markers – its effectiveness and limitations. Drug Discoveries & Therapeutics 9:2, pages 129-132.
Crossref
A. Frena. (2018) SPan-1 and Exocrine Pancreatic Carcinoma. The Clinical Role of a New Tumor Marker. The International Journal of Biological Markers 16:3, pages 189-197.
Crossref
M. Plebani, D. Basso, M.P. Panozzo, P. Fogar, G. Del Favero & R. Naccarato. (2018) Tumor Markers in the Diagnosis, Monitoring and Therapy of Pancreatic Cancer: State of the Art. The International Journal of Biological Markers 10:4, pages 189-199.
Crossref
Maureen A. Chung & Helena R. Chang. (2006) Clinical use of tumor markers in pancreatic carcinoma. Seminars in Surgical Oncology 11:2, pages 103-107.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.